ARAY | Accuray Inc |
Surgical & Medical Instruments & Apparatus |
Book value per $ invested | $ 0.21 |
Leverage | 90.44% |
Market Cap | $ 217.2m |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -16.5m |
Margin | -3.80% |
Accuray Incorporated designs, develops and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa and the rest of the Asia Pacific region. The company is headquartered in Sunnyvale, California.